SEATTLE, Feb. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) today announced that Dan Eramian, former Vice President of Communications at Biotechnology Industry Organization (BIO), will join the Company in early March as Executive Vice President of Corporate Communications. Eramian will serve as a member of the Company’s senior management team and will be responsible for developing and implementing the internal and external communications strategy. Eramian brings nearly 13 years of experience in the biotechnology industry to the position.
“We are very pleased to have Dan join the senior management team. His wealth of industry knowledge and experience has earned him the trust and respect of his colleagues,” said James A. Bianco, M.D., President and CEO of CTI. “We are confident that his experience and leadership will be an asset to CTI.”
Most recently Eramian was Vice President of Communications at BIO, a Washington, DC-based industry organization representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations. Prior to BIO, Eramian was Assistant Administrator of Communications at the Small Business Administration and Director of Public Affairs at the Department of Justice and Chief Spokesman for the Attorney General.
“In my 13 years at BIO, I have worked with scores of fine CEOs and member companies,” stated Eramian. “I am especially excited about joining the CTI team and contributing to their bright future.”
“CTI has landed a significant asset. Dan Eramian is a highly experienced professional and has performed exceptionally well at the international, national, and local levels without ever losing his rare common touch,” noted Carl B. Feldbaum, president emeritus and former president of BIO.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.cticseattle.com.
Cell Therapeutics, Inc.
CONTACT: investors, Leah Grant, +1-206-282-7100, or fax, +1-206-272-4434,or invest@ctiseattle.com, or media, Susan Callahan, +1-206-272-4472, orfax, +1-206-272-4434, or media@ctiseattle.com, both of Cell Therapeutics,Inc.
Web site: http://www.cticseattle.com/
